Plus Therapeutics to trade on Nasdaq as Cerenome under CNSY ticker from Aug. 3PUBT·2 days ago, 07:32 AMPSTV+6.03%CNSY
Cerenome Launches as an Integrated CNS Oncology Company | PSTV Stock NewsStockTitan·2 days ago, 11:30 PMPSTV+6.03%CNSY
Plus Therapeutics signs Medical Mutual coverage deal for CNSide CSF tumor cell assay in Ohio, KentuckyPUBT·Jul 21 at 06:30 AMPSTV+6.03%CNSY
Plus Therapeutics partners with Genomic Testing Cooperative to add NGS to CNSide CSF assay platformPUBT·Jul 16 at 06:31 AMPSTV+6.03%CNSY
From Buybacks to Insider Buying: U.S. Mid-Caps Signal Capital ShiftGlobal Report·Jul 14 at 06:47 AMBDX+0.10%AB+0.11%
Plus Therapeutics flags availability of CNS cancers guidelines update releasePUBT·Jul 14 at 06:31 AMPSTV+6.03%CNSY
PSTV: Cerenome advances CNS oncology with integrated therapeutics, diagnostics, and native AIQuartr·Jun 30 at 09:40 AMPSTV+6.03%CNSY
Plus Therapeutics reaffirms 2026 milestones guidance for CNSide diagnostics businessPUBT·Jun 30 at 06:35 AMPSTV+6.03%CNSY
Plus Therapeutics rebrands as Cerenome, to trade as CNSY on Nasdaq from Aug. 3, 2026PUBT·Jun 30 at 06:31 AMPSTV+6.03%CNSY
Plus Therapeutics unit CNSide signs national coverage deal with Elevance Health for CSF cancer assayPUBT·Jun 25 at 06:30 AMPSTV+6.03%ELV-0.15%
Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Mondaybenzinga_article·Jun 8 at 08:52 AMNAVN-0.34%TOI-4.14%
Plus Therapeutics | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 1.028 MEarnings Watch·May 15 at 03:19 PMPSTV+6.03%CNSY
